相关实验视频
Updated: Jan 29, 2026
09:54
A Model to Simulate Clinically Relevant Hypoxia in Humans
Published on: December 22, 2016
9.3K
碎片引导的新疗法分子 发现和绘制临床相关的互动体的图谱
Austė Kanapeckaitė1,2, Sarper Okuyan3, David James Wagg4,5
1Columbia University Irving Medical Center, 630 W. 168th St., New York, New York 10032, United States.
Journal of chemical information and modeling
|January 28, 2026
概括
这项研究引入了一种用于药物发现的新型神经网络方法,使用分子碎片来识别JAK2和GLP-1R点的新疗法候选者. 该方法增强了in silico结合,预测了副作用,并有助于临床策略选择.
科学领域:
- 药理学和化学信息学
- 计算生物学 计算生物学
- 药物发现 药物发现 药物发现
背景情况:
- 目前的药物发现严重依赖于大型化学数据集,经常忽视特定的分子贡献.
- 需要改进药物发现和表征方法,以指导临床策略.
- 针对性调节病理途径对于治疗复杂疾病至关重要.
研究的目的:
- 提出针对性疗法开发和使用分子碎片进行互动组映射的新视角.
- 开发和应用一种自我调整的神经网络,用于识别新型治疗候选者.
- 探索药物重用和副作用预测的新途径.
主要方法:
- 利用自我调整的神经网络进行in silico药物发现.
- 采用分子碎片用于向疗法开发和互动组映射.
- 专注于新兴的治疗点:JAK2和GLP-1受体 (GLP-1R).
主要成果:
- 发现了具有增强的in silico结合配置的新型治疗候选者.
- 获得了对药物向相互作用的新见解,并确定了新的代谢轨迹.
- 证明小型复合库可以有效地产生领先的候选人,加速发现过程.
- 通过碎片引导的化学和生物空间桥梁,揭示了药物重新用途和改善副作用预测的机会.
结论:
- 具有集成查数据的强大的in silico管道可以显著降低成本并指导治疗采用.
- 拟议的碎片引导方法为发现新疗法和开发临床干预提供了有希望的途径.
- 这种方法可能会防止最近的高调临床试验失败,如danuglipron.
相关概念视频
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
215
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
215
02:31Habitat Fragmentation
21.3K
Habitat fragmentation describes the division of a more extensive, continuous habitat into smaller, discontinuous areas. Human activities such as land conversion, as well as slower geological processes leading to changes in the physical environment, are the two leading causes of habitat fragmentation. The fragmentation process typically follows the same steps: perforation, dissection, fragmentation, shrinkage, and attrition.
21.3K
01:26Drug Discovery: Overview
11.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.4K
02:38Molecules and Compounds
68.6K
Atoms and Molecules
68.6K
01:13Therapeutic Index
6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
00:59Mass Spectrometry: Alkene Fragmentation
3.6K
Alkenes lose one electron from the unsaturated π bond upon ionization and form stable molecular ions. Further fragmentation of alkenes occurs through three different reaction pathways. The most prominent fragmentation is the cleavage at the allylic position. The resultant allylic carbocation is resonance stabilized. In the mass spectra of terminal alkenes, this fragment appears at a mass-to-charge ratio of 41. In the internal alkenes, where there are two choices of allylic cleavage, the...
3.6K